Table 2. Patient characteristics with functional visceral fat activity.
| V/S ratio>1.88 (36 patients) | V/S ratio≤1.88 (95 patients) | p | |
|---|---|---|---|
| Age (years) | 64±12 | 64±11 | 0.173 |
| Sex | 0.494 | ||
| Male | 20 (55.6%) | 59 (62.1%) | |
| Female | 16 (44.4%) | 36 (37.9%) | |
| Tumor location | 0.734 | ||
| Colon | 25 (69.4%) | 63 (66.3%) | |
| Rectum | 11 (30.6%) | 32 (33.7%) | |
| Differentiation | 0.217 | ||
| Well | 4 (11.1%) | 20 (21.1%) | |
| Moderate and poor | 32 (88.9%) | 75 (78.9%) | |
| pT stage | 0.186 | ||
| Tis-T2 | 3 (8.3%) | 18 (18.9%) | |
| T3-T4 | 33 (91.7%) | 77 (81.1%) | |
| N stage | 0.004* | ||
| Negative | 11 (30.6%) | 56 (58.9%) | |
| Positive | 25 (69.4%) | 39 (41.1%) | |
| M stage | <0.001* | ||
| M0 | 25 (69.4%) | 93 (97.9%) | |
| M1 | 11 (30.6%) | 2 (2.1%) | |
| AJCC stage | 0.003* | ||
| 0-II | 10 (27.8%) | 55 (57.9%) | |
| III-IV | 26 (72.2%) | 40 (42.1%) | |
| Lymphatic invasion | 0.025* | ||
| Negative | 21 (58.3%) | 74 (77.9%) | |
| Positive | 15 (41.7%) | 21 (22.1%) | |
| Venous invasion | 0.615 | ||
| Negative | 34 (94.4%) | 92 (96.8%) | |
| Positive | 2 (5.6%) | 3 (3.2%) | |
| Perineural invasion | 0.137 | ||
| Negative | 31 (86.1%) | 90 (94.7%) | |
| Positive | 5 (13.9%) | 5 (5.3%) |
SUVmax = maximum standardized uptake value
V/S ratio = Visceral fat SUVmax/Subcutaneous fat SUVmax ratio
AJCC = American Joint Committee on Cancer
pT stage = Pathologic T stage
* Statistically significant difference